SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009917
Filing Date
2017-05-09
Accepted
2017-05-09 16:48:53
Documents
49
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20170331.htm 10-Q 1436456
2 EX-31.1 xene-ex311_9.htm EX-31.1 18948
3 EX-31.2 xene-ex312_8.htm EX-31.2 19140
4 EX-32.1 xene-ex321_7.htm EX-32.1 11672
5 EX-32.2 xene-ex322_6.htm EX-32.2 11684
  Complete submission text file 0001564590-17-009917.txt   3339962

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xene-20170331.xml EX-101.INS 442418
7 XBRL TAXONOMY EXTENSION SCHEMA xene-20170331.xsd EX-101.SCH 28532
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20170331_cal.xml EX-101.CAL 28193
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20170331_def.xml EX-101.DEF 50259
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20170331_lab.xml EX-101.LAB 194857
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20170331_pre.xml EX-101.PRE 140574
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 17827217
SIC: 2834 Pharmaceutical Preparations